News from mylan n.v.
A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages
10 Apr, 2018, 12:30 BST Mylan to Acquire the Global Marketing Rights to a Once-monthly Glatiramer Acetate Product through an Investment and Partnership with Israeli Company Mapi Pharma
Mylan N.V. (NASDAQ: MYL), one of the world's leading pharmaceutical companies, and Mapi Pharma Ltd., a fully integrated, clinical late stage...
08 Jun, 2015, 08:00 BST Mylan Launches First Bioequivalent Alternative to Combination Asthma Therapy Seretide® Evohaler® (Salmeterol Xinafoate/Fluticasone Propionate) Under the Brand Name Sirdupla™ in the UK
Mylan N.V. (Nasdaq: MYL) today announced that it has launched the first bioequivalent alternative to GlaxoSmithKline's Seretide® Evohaler®...